Global Streptococcus Pneumoniae Vaccine Market Research Report 2021

1 Streptococcus Pneumoniae Vaccine Market Overview

• 1.1 Product Overview and Scope of Streptococcus Pneumoniae Vaccine
• 1.2 Streptococcus Pneumoniae Vaccine Segment by Type
  • 1.2.1 Global Streptococcus Pneumoniae Vaccine Sales Growth Rate Comparison by Type (2021-2027)
  • 1.2.2 7 -Valent
  • 1.2.3 10 -Valent
  • 1.2.4 13 -Valent
  • 1.2.5 15 -Valent
  • 1.2.6 23 -Valent
  • 1.2.7 Other
• 1.3 Streptococcus Pneumoniae Vaccine Segment by Application
  • 1.3.1 Global Streptococcus Pneumoniae Vaccine Sales Comparison by Application: (2021-2027)
  • 1.3.2 Children under 2 Years of Age
  • 1.3.3 Adults over 65 Years of Age
  • 1.3.4 Addicted Smokers Between the Ages of 19 and 64
  • 1.3.5 Other
• 1.4 Global Streptococcus Pneumoniae Vaccine Market Size Estimates and Forecasts
  • 1.4.1 Global Streptococcus Pneumoniae Vaccine Revenue 2016-2027
  • 1.4.2 Global Streptococcus Pneumoniae Vaccine Sales 2016-2027
  • 1.4.3 Streptococcus Pneumoniae Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027

2 Streptococcus Pneumoniae Vaccine Market Competition by Manufacturers

• 2.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Manufacturers (2016-2021)
• 2.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Manufacturers (2016-2021)
• 2.3 Global Streptococcus Pneumoniae Vaccine Average Price by Manufacturers (2016-2021)
• 2.4 Manufacturers Streptococcus Pneumoniae Vaccine Manufacturing Sites, Area Served, Product Type
• 2.5 Streptococcus Pneumoniae Vaccine Market Competitive Situation and Trends
  • 2.5.1 Streptococcus Pneumoniae Vaccine Market Concentration Rate
  • 2.5.2 The Global Top 5 and Top 10 Largest Streptococcus Pneumoniae Vaccine Players Market Share by Revenue
  • 2.5.3 Global Streptococcus Pneumoniae Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Streptococcus Pneumoniae Vaccine Retrospective Market Scenario by Region

• 3.1 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
• 3.2 Global Streptococcus Pneumoniae Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
• 3.3 North America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
  • 3.3.1 North America Streptococcus Pneumoniae Vaccine Sales by Country
  • 3.3.2 North America Streptococcus Pneumoniae Vaccine Revenue by Country
  • 3.3.3 United States
  • 3.3.4 Canada
• 3.4 Europe Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
  • 3.4.1 Europe Streptococcus Pneumoniae Vaccine Sales by Country
  • 3.4.2 Europe Streptococcus Pneumoniae Vaccine Revenue by Country
  • 3.4.3 Germany
  • 3.4.4 France
  • 3.4.5 U.K.
  • 3.4.6 Italy
  • 3.4.7 Russia
• 3.5 Asia Pacific Streptococcus Pneumoniae Vaccine Market Facts & Figures by Region
  • 3.5.1 Asia Pacific Streptococcus Pneumoniae Vaccine Sales by Region
  • 3.5.2 Asia Pacific Streptococcus Pneumoniae Vaccine Revenue by Region
  • 3.5.3 China
  • 3.5.4 Japan
  • 3.5.5 South Korea
  • 3.5.6 India
  • 3.5.7 Australia
  • 3.5.8 Taiwan
  • 3.5.9 Indonesia
  • 3.5.10 Thailand
  • 3.5.11 Malaysia
• 3.6 Latin America Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
  • 3.6.1 Latin America Streptococcus Pneumoniae Vaccine Sales by Country
  • 3.6.2 Latin America Streptococcus Pneumoniae Vaccine Revenue by Country
  • 3.6.3 Mexico
  • 3.6.4 Brazil
  • 3.6.5 Argentina
  • 3.6.6 Colombia
• 3.7 Middle East and Africa Streptococcus Pneumoniae Vaccine Market Facts & Figures by Country
  • 3.7.1 Middle East and Africa Streptococcus Pneumoniae Vaccine Sales by Country
  • 3.7.2 Middle East and Africa Streptococcus Pneumoniae Vaccine Revenue by Country
  • 3.7.3 Turkey
  • 3.7.4 Saudi Arabia
  • 3.7.5 UAE

4 Global Streptococcus Pneumoniae Vaccine Historic Market Analysis by Type

• 4.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Type (2016-2021)
• 4.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Type (2016-2021)
• 4.3 Global Streptococcus Pneumoniae Vaccine Price by Type (2016-2021)

5 Global Streptococcus Pneumoniae Vaccine Historic Market Analysis by Application

• 5.1 Global Streptococcus Pneumoniae Vaccine Sales Market Share by Application (2016-2021)
• 5.2 Global Streptococcus Pneumoniae Vaccine Revenue Market Share by Application (2016-2021)
• 5.3 Global Streptococcus Pneumoniae Vaccine Price by Application (2016-2021)

6 Key Companies Profiled

• 6.1 Pfizer
  • 6.1.1 Pfizer Corporation Information
  • 6.1.2 Pfizer Description and Business Overview
  • 6.1.3 Pfizer Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.1.4 Pfizer Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.1.5 Pfizer Recent Developments/Updates
• 6.2 Sanofi
  • 6.2.1 Sanofi Corporation Information
  • 6.2.2 Sanofi Description and Business Overview
  • 6.2.3 Sanofi Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.2.4 Sanofi Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.2.5 Sanofi Recent Developments/Updates
• 6.3 GSK
  • 6.3.1 GSK Corporation Information
  • 6.3.2 GSK Description and Business Overview
  • 6.3.3 GSK Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.3.4 GSK Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.3.5 GSK Recent Developments/Updates
• 6.4 Merck
  • 6.4.1 Merck Corporation Information
  • 6.4.2 Merck Description and Business Overview
  • 6.4.3 Merck Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Merck Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.4.5 Merck Recent Developments/Updates
• 6.5 Eli Lilly
  • 6.5.1 Eli Lilly Corporation Information
  • 6.5.2 Eli Lilly Description and Business Overview
  • 6.5.3 Eli Lilly Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.5.4 Eli Lilly Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.5.5 Eli Lilly Recent Developments/Updates
• 6.6 AstraZeneca
  • 6.6.1 AstraZeneca Corporation Information
  • 6.6.2 AstraZeneca Description and Business Overview
  • 6.6.3 AstraZeneca Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.6.4 AstraZeneca Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.6.5 AstraZeneca Recent Developments/Updates
• 6.7 Abera
  • 6.6.1 Abera Corporation Information
  • 6.6.2 Abera Description and Business Overview
  • 6.6.3 Abera Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.4.4 Abera Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.7.5 Abera Recent Developments/Updates
• 6.8 S K Chemicals
  • 6.8.1 S K Chemicals Corporation Information
  • 6.8.2 S K Chemicals Description and Business Overview
  • 6.8.3 S K Chemicals Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.8.4 S K Chemicals Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.8.5 S K Chemicals Recent Developments/Updates
• 6.9 Beijing Minhai Biotechnology
  • 6.9.1 Beijing Minhai Biotechnology Corporation Information
  • 6.9.2 Beijing Minhai Biotechnology Description and Business Overview
  • 6.9.3 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.9.4 Beijing Minhai Biotechnology Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.9.5 Beijing Minhai Biotechnology Recent Developments/Updates
• 6.10 Baxter
  • 6.10.1 Baxter Corporation Information
  • 6.10.2 Baxter Description and Business Overview
  • 6.10.3 Baxter Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.10.4 Baxter Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.10.5 Baxter Recent Developments/Updates
• 6.11 Biken
  • 6.11.1 Biken Corporation Information
  • 6.11.2 Biken Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.11.3 Biken Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.11.4 Biken Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.11.5 Biken Recent Developments/Updates
• 6.12 Celgene Corporation
  • 6.12.1 Celgene Corporation Corporation Information
  • 6.12.2 Celgene Corporation Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.12.3 Celgene Corporation Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.12.4 Celgene Corporation Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.12.5 Celgene Corporation Recent Developments/Updates
• 6.13 Panacea Biotec
  • 6.13.1 Panacea Biotec Corporation Information
  • 6.13.2 Panacea Biotec Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.13.3 Panacea Biotec Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.13.4 Panacea Biotec Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.13.5 Panacea Biotec Recent Developments/Updates
• 6.14 Serum Institute of India
  • 6.14.1 Serum Institute of India Corporation Information
  • 6.14.2 Serum Institute of India Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.14.3 Serum Institute of India Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.14.4 Serum Institute of India Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.14.5 Serum Institute of India Recent Developments/Updates
• 6.15 Genentech
  • 6.15.1 Genentech Corporation Information
  • 6.15.2 Genentech Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.15.3 Genentech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.15.4 Genentech Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.15.5 Genentech Recent Developments/Updates
• 6.16 Genocea Biosciences
  • 6.16.1 Genocea Biosciences Corporation Information
  • 6.16.2 Genocea Biosciences Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.16.3 Genocea Biosciences Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.16.4 Genocea Biosciences Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.16.5 Genocea Biosciences Recent Developments/Updates
• 6.17 ImmunoBiology
  • 6.17.1 ImmunoBiology Corporation Information
  • 6.17.2 ImmunoBiology Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.17.3 ImmunoBiology Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.17.4 ImmunoBiology Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.17.5 ImmunoBiology Recent Developments/Updates
• 6.18 Lupin
  • 6.18.1 Lupin Corporation Information
  • 6.18.2 Lupin Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.18.3 Lupin Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.18.4 Lupin Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.18.5 Lupin Recent Developments/Updates
• 6.19 Nuron Biotech
  • 6.19.1 Nuron Biotech Corporation Information
  • 6.19.2 Nuron Biotech Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.19.3 Nuron Biotech Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.19.4 Nuron Biotech Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.19.5 Nuron Biotech Recent Developments/Updates
• 6.20 Biogen
  • 6.20.1 Biogen Corporation Information
  • 6.20.2 Biogen Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.20.3 Biogen Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.20.4 Biogen Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.20.5 Biogen Recent Developments/Updates
• 6.21 Valneva Austria
  • 6.21.1 Valneva Austria Corporation Information
  • 6.21.2 Valneva Austria Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.21.3 Valneva Austria Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.21.4 Valneva Austria Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.21.5 Valneva Austria Recent Developments/Updates
• 6.22 Sinovac
  • 6.22.1 Sinovac Corporation Information
  • 6.22.2 Sinovac Streptococcus Pneumoniae Vaccine Description and Business Overview
  • 6.22.3 Sinovac Streptococcus Pneumoniae Vaccine Sales, Revenue and Gross Margin (2016-2021)
  • 6.22.4 Sinovac Streptococcus Pneumoniae Vaccine Product Portfolio
  • 6.22.5 Sinovac Recent Developments/Updates

7 Streptococcus Pneumoniae Vaccine Manufacturing Cost Analysis

• 7.1 Streptococcus Pneumoniae Vaccine Key Raw Materials Analysis
  • 7.1.1 Key Raw Materials
  • 7.1.2 Key Suppliers of Raw Materials
• 7.2 Proportion of Manufacturing Cost Structure
• 7.3 Manufacturing Process Analysis of Streptococcus Pneumoniae Vaccine
• 7.4 Streptococcus Pneumoniae Vaccine Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Streptococcus Pneumoniae Vaccine Distributors List
• 8.3 Streptococcus Pneumoniae Vaccine Customers

9 Streptococcus Pneumoniae Vaccine Market Dynamics

• 9.1 Streptococcus Pneumoniae Vaccine Industry Trends
• 9.2 Streptococcus Pneumoniae Vaccine Growth Drivers
• 9.3 Streptococcus Pneumoniae Vaccine Market Challenges
• 9.4 Streptococcus Pneumoniae Vaccine Market Restraints

10 Global Market Forecast

• 10.1 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Type
  • 10.1.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Type (2022-2027)
  • 10.1.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Type (2022-2027)
• 10.2 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Application
  • 10.2.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Application (2022-2027)
  • 10.2.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Application (2022-2027)
• 10.3 Streptococcus Pneumoniae Vaccine Market Estimates and Projections by Region
  • 10.3.1 Global Forecasted Sales of Streptococcus Pneumoniae Vaccine by Region (2022-2027)
  • 10.3.2 Global Forecasted Revenue of Streptococcus Pneumoniae Vaccine by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
  • 12.1.1 Research Programs/Design
  • 12.1.2 Market Size Estimation
  • 12.1.3 Market Breakdown and Data Triangulation
• 12.2 Data Source
  • 12.2.1 Secondary Sources
  • 12.2.2 Primary Sources
• 12.3 Author List